Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.35 CAD
Change Today +0.005 / 1.47%
Volume 33.2K
TST On Other Exchanges
Symbol
Exchange
TST is not on other exchanges.
As of 10:20 AM 05/25/15 All times are local (Market data is delayed by at least 15 minutes).

telesta therapeutics inc (TST) Snapshot

Open
C$0.35
Previous Close
C$0.34
Day High
C$0.35
Day Low
C$0.35
52 Week High
07/21/14 - C$0.44
52 Week Low
06/2/14 - C$0.14
Market Cap
58.3M
Average Volume 10 Days
288.3K
EPS TTM
C$0.04
Shares Outstanding
169.1M
EX-Date
--
P/E TM
7.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for TELESTA THERAPEUTICS INC (TST)

Related News

No related news articles were found.

telesta therapeutics inc (TST) Related Businessweek News

No Related Businessweek News Found

telesta therapeutics inc (TST) Details

Telesta Therapeutics Inc., a late clinical stage biopharmaceutical company, engages in the development, manufacture, marketing, and licensing/acquisition of proprietary and therapeutic products for the human health markets worldwide. Its lead product, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) suspension, is a complex biologic immunotherapy/immunomodulator designed for the treatment of non-muscle-invasive bladder cancer in humans, which has completed Phase III clinical trials. The company was formerly known as Bioniche Life Sciences Inc. and changed its name to Telesta Therapeutics Inc. in November 2014. Telesta Therapeutics Inc. was founded in 1979 and is headquartered in Belleville, Canada.

Founded in 1979

telesta therapeutics inc (TST) Top Compensated Officers

Chief Executive Officer, Chief Scientist Offi...
Total Annual Compensation: C$256.3K
Founder, Chairman Emeritus and Board Observer
Total Annual Compensation: C$132.6K
Chief Financial Officer
Total Annual Compensation: C$225.0K
Chief Operating Officer and Corporate Secreta...
Total Annual Compensation: C$130.0K
Vice President of Manufacturing Operations
Total Annual Compensation: C$201.6K
Compensation as of Fiscal Year 2014.

telesta therapeutics inc (TST) Key Developments

Telesta Therapeutics Inc. Presents at Bloom Burton & Co. Inc. Healthcare Investor Conference, May-04-2015 02:00 PM

Telesta Therapeutics Inc. Presents at Bloom Burton & Co. Inc. Healthcare Investor Conference, May-04-2015 02:00 PM. Venue: Sheraton Centre Toronto Hotel (Corner of York and Queen St. West), Toronto, Ontario, M5H 3M9, Canada.

Telesta Therapeutics Inc. to Report Q2, 2015 Results on Feb 13, 2015

Telesta Therapeutics Inc. announced that they will report Q2, 2015 results at 10:37 AM, GMT Standard Time on Feb 13, 2015

Telesta Therapeutics Inc. Presents at BIO-Europe Spring 2015, Mar-09-2015

Telesta Therapeutics Inc. Presents at BIO-Europe Spring 2015, Mar-09-2015 . Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TST:CN C$0.35 CAD +0.005

TST Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TST.
View Industry Companies
 

Industry Analysis

TST

Industry Average

Valuation TST Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 319.9x
Price/Book NM Not Meaningful
Price/Cash Flow 1.7x
TEV/Sales 243.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELESTA THERAPEUTICS INC, please visit www.telestatherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.